STAT

Updating drug labels would greatly help patients — but few companies do it

Many drug labels are out of date. Congress should give the FDA the authority to encourage drug manufacturers to keep this essential information up to date.
Source: APStock

Do you ever look at the labels of the prescription medications you take? Or do you simply rely on your physician to read them to understand the medications’ appropriate uses and side effects? Either way, there’s a good chance that these labels — the detailed instructions for use that accompany every drug approved by the Food and Drug Administration — are out of date and lacking essential new information for appropriate use and safety.

Accurate drug labeling is fundamental to safe and effective prescribing and

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

Related Books & Audiobooks